Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?

Stroke. 2003 Feb;34(2):354-6. doi: 10.1161/01.str.0000054261.97525.4b.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Angiotensin II / physiology
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Benzimidazoles / therapeutic use
  • Benzoates / therapeutic use
  • Blood Pressure / drug effects
  • Clinical Trials as Topic / statistics & numerical data
  • Diuretics / adverse effects
  • Diuretics / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Hypertension / drug therapy
  • Life Style
  • Practice Guidelines as Topic
  • Ramipril / adverse effects
  • Ramipril / therapeutic use
  • Risk
  • Risk Factors
  • Stroke / prevention & control*
  • Telmisartan

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Diuretics
  • Angiotensin II
  • Ramipril
  • Telmisartan